按病种付费！你的医保有这些新变化→

Core Points - The article discusses the implementation of a new payment reform in China's healthcare system, focusing on a disease-based payment model to improve efficiency and reduce excessive medical practices [1][2] - The National Healthcare Security Administration (NHSA) has issued interim measures to establish a dynamic adjustment mechanism for disease grouping schemes, aiming for adjustments every two years [1][2] Summary by Sections Payment Reform Overview - The traditional payment method in China's healthcare system is based on itemized billing, which can lead to over-treatment and unnecessary medical procedures [1] - Since 2019, the NHSA has been piloting the disease-based payment model, which groups patients by similar conditions and sets a standard payment based on historical data [1] Implementation and Challenges - After six years, the disease-based payment model has expanded from pilot programs to a nationwide implementation, covering all coordinated areas and improving the efficiency of healthcare fund usage [1] - Challenges remain, including insufficient expectations for dynamic adjustments, uneven development of supporting measures across regions, and varying levels of management capabilities [1] New Measures and Goals - The new measures aim for a standardized framework focusing on total budget management, grouping schemes, and core elements [2] - The NHSA emphasizes the importance of a rigid total budget and collaborative development of grouping schemes with healthcare institutions [2] - The introduction of these measures marks a shift from "scale expansion" to "precise regulation," aiming to reduce regional management disparities and enhance the role of healthcare institutions in the payment reform process [2]